Aster DM Sees Potential to Grow Oncology's Share to High Teens

In a rapidly evolving health care landscape, operational efficiency, technological advancement, and patient-centric models are a major focus. Alisha Moopen, deputy managing director of Aster DM Healthcare, in a video interview with Aneeka Chatterjee, sheds light on how her firm is driving improvements in average length of stay (ALOS) through a combination of clinical innovation. Edited excerpts:

- 

How is higher ALOS impacting patient outcomes? What are your plans to sustain this momentum?

We monitor the average length of stay very closely, not just from an operational efficiency perspective, but more importantly, in terms of patient outcomes. Several factors have contributed to the recent improvements. There is a growing emphasis on minimally invasive surgeries, including robotic and orthopedic procedures, which often allow for shorter hospital stays or even same-day discharges. We also work closely with payers such as third-party administrators (TPAs) and insurance companies to streamline the discharge process. While paperwork can sometimes cause delays, better coordination ensures that patients can return home sooner. This shift is driven by evolving care models and increased adoption of technologies like robotic surgery.